About Us | Contact

Dr. George Konis Investigator

NPI1902884372
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$17,059.59
from 29 payments in the last 6 years

Total Cash or Cash Equivalent

$12,608.62
from 11 payments in the last 6 years

Total In-kind Items & Services

$4,450.97
from 18 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
09/18/2021 General (Non-Research) In-kind items and services Food and Beverage $188.86 Details
Payment from Allergan, Inc.
Payment Record ID 792838955
09/17/2021 General (Non-Research) In-kind items and services Travel and Lodging $225.80 Details
Payment from Allergan, Inc.
Payment Record ID 792838953
09/17/2021 General (Non-Research) In-kind items and services Travel and Lodging $236.17 Details
Payment from Allergan, Inc.
Payment Record ID 792838951
12/01/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $3005.00 Details
Payment from Indivior Inc.
Payment Record ID 753807703
03/11/2019 General (Non-Research) In-kind items and services Food and Beverage $441.76 Details
Payment from PFIZER INC.
Payment Record ID 672123891
03/11/2019 General (Non-Research) In-kind items and services Travel and Lodging $423.40 Details
Payment from PFIZER INC.
Payment Record ID 672123887
03/11/2019 General (Non-Research) In-kind items and services Travel and Lodging $189.00 Details
Payment from PFIZER INC.
Payment Record ID 672123881
12/01/2018 General (Non-Research) In-kind items and services Food and Beverage $256.94 Details
Payment from Indivior Inc.
Payment Record ID 615478331
12/01/2018 General (Non-Research) In-kind items and services Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $256.94 Details
Payment from Indivior Inc.
Payment Record ID 615478327
11/30/2018 General (Non-Research) In-kind items and services Travel and Lodging $123.17 Details
Payment from Indivior Inc.
Payment Record ID 615478323
11/30/2018 General (Non-Research) In-kind items and services Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $123.17 Details
Payment from Indivior Inc.
Payment Record ID 615478319
01/24/2018 Research Cash or cash equivalent Drug $818.30 Details
Payment from Indivior Inc.
Paymment Research Study An Open-Label, Depot Buprenorphine RBP-6000 Treatment Extension Study in Subjects With Opioid Use Disorder
Clinical Trials Gov ID NCT02896296
Payment Record ID 615442507
06/04/2018 General (Non-Research) In-kind items and services Food and Beverage $90.77 Details
Payment from Vanda Pharmaceuticals Inc.
Payment Record ID 612320721
11/07/2018 General (Non-Research) In-kind items and services Food and Beverage $20.13 Details
Payment from Neurocrine Biosciences, Inc.
Payment Record ID 604143857
10/18/2016 General (Non-Research) In-kind items and services Travel and Lodging $816.16 Details
Payment from Roche Products Limited
Payment Record ID 513178397
10/18/2016 General (Non-Research) In-kind items and services Food and Beverage $337.91 Details
Payment from Roche Products Limited
Payment Record ID 513178395
10/18/2016 General (Non-Research) In-kind items and services Travel and Lodging $315.78 Details
Payment from Roche Products Limited
Payment Record ID 513178393
01/19/2017 Research Cash or cash equivalent $100.00 Details
Payment from Dr.Reddy's Laboratories,Inc.
Paymment Research Study A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib
Payment Record ID 506350401
12/03/2016 Research Cash or cash equivalent $460.90 Details
Payment from Dr.Reddy's Laboratories,Inc.
Paymment Research Study A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib
Payment Record ID 421207301
12/03/2016 Research Cash or cash equivalent $850.78 Details
Payment from Dr.Reddy's Laboratories,Inc.
Paymment Research Study A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib
Payment Record ID 421207299
12/02/2016 Research Cash or cash equivalent $197.01 Details
Payment from Dr.Reddy's Laboratories,Inc.
Paymment Research Study A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib
Payment Record ID 421207297
12/01/2016 Research Cash or cash equivalent $132.51 Details
Payment from Dr.Reddy's Laboratories,Inc.
Paymment Research Study A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib
Payment Record ID 421207295
12/03/2016 Research Cash or cash equivalent $200.15 Details
Payment from Dr.Reddy's Laboratories,Inc.
Paymment Research Study A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib
Payment Record ID 421207293
10/14/2016 Research Cash or cash equivalent $525.09 Details
Payment from Noven Pharmaceuticals, Inc.
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIXED-DOSE, 6-WEEK, IN-PATIENT STUDY TO ASSESS EFFICACY AND SAFETY OF HP-3070 IN SUBJECTS DIAGNOSED WITH SCHIZOPHRENIA
Payment Record ID 417598095
12/31/2016 Research Cash or cash equivalent Drug $6307.10 Details
Payment from Indivior Inc.
Paymment Research Study INDV-6000-301
Payment Record ID 411859642
08/05/2016 General (Non-Research) In-kind items and services Food and Beverage $282.03 Details
Payment from Pfizer Inc.
Payment Record ID 404855332
08/05/2016 General (Non-Research) In-kind items and services Travel and Lodging $82.57 Details
Payment from Pfizer Inc.
Payment Record ID 404461204
05/26/2016 General (Non-Research) In-kind items and services Food and Beverage $40.41 Details
Payment from Alkermes, Inc.
Payment Record ID 395817314
12/20/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $11.78 Details
Payment from Convatec Inc.
Payment Record ID 392791486
;